Currently out of the existing stock ratings of Craig Hettenbach, 97 are a HOLD (40.59%), 33 are a SELL (13.81%), 109 are a BUY (45.61%).

Craig Hettenbach

Work Performance Price Targets & Ratings Chart

Analyst Craig Hettenbach, currently employed at MORGAN STANLEY, carries an average stock price target met ratio of 72.13% that have a potential upside of 17.98% achieved within 188 days.

Craig Hettenbach’s has documented 570 price targets and ratings displayed on 29 stocks. The coverage is on Technology, Healthcare, Consumer Defensive sectors.

Most recent stock forecast was given on VEEV, Veeva Systems at 05-Mar-2026.

Wall Street Analyst Craig Hettenbach

Analyst best performing recommendations are on HIMS (HIMS HERS HEALTH).
The best stock recommendation documented was for WOLF (WOLFSPEED) at 4/26/2021. The price target of $100 was fulfilled within 3 days with a profit of $19.02 (15.98%) receiving and performance score of 53.27.

Average potential price target upside

of $46.15 (13.41%) on HCA (HCA HOLDINGS).
of $38.51 (15.32%) on VEEV (VEEVA SYSTEMS).
of $38.26 (24.17%) on THC (TENET HEALTHCARE).

ADI Analog Devices APH Amphenol AVGO Broadcom CREE Cree CY Cypress Semiconductor MCHP Microchip Technology NXPI NXP Semiconductors NV ON ON Semiconductor PI Impinj QRVO Qorvo ST Sensata Technologies Holding NV SWKS Skyworks Solutions TEL TE Connectivity Ltd TXN Texas Instruments DH Definitive Healthcare Corp WOLF Wolfspeed SLAB Silicon Laboratories SHCR Sharecare RCM R1 RCM MODN Model N DOCS Doximity AMWL American Well Corp VEEV Veeva Systems GDRX Goodrx Holdings HCA HCA Holdings ARDT Ardent Health Partners HIMS Hims Hers Health THC Tenet Healthcare UHS Universal Health Services

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Timothy Arcuri (UBS)